Double blind trial of bezafibrate in familial hypercholesterolaemia.

Kathryn Wheeler, R. West, J. K. Lloyd, J. Barley

Archives of Disease in Childhood · 1985 · 90 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

A six month, double blind, crossover controlled trial of bezafibrate was conducted in 14 children with familial hypercholesterolaemia all of whom had a strong family history of early coronary heart disease. The bezafibrate was given twice daily in a dose of 10 to 20 mg/kg/day. The mean plasma total cholesterol concentration on bezafibrate was 22% lower than during the period on placebo and there was a moderate rise in high density lipoprotein cholesterol. Bezafibrate may be a useful adjunct to treatment in these children.

References

6